{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:34:10Z","timestamp":1784230450175,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T00:00:00Z","timestamp":1331251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T00:00:00Z","timestamp":1331251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/leu.2012.67","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T07:38:03Z","timestamp":1331278683000},"page":"1892-1895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants"],"prefix":"10.1038","volume":"26","author":[{"given":"Z-X","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R-L","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-L","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-R","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-Z","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-Q","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-Y","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,9]]},"reference":[{"key":"BFleu201267_CR1","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1182\/blood-2008-01-133355","volume":"11","author":"M Jongen-Lavrencic","year":"2008","unstructured":"Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJM, L\u00f6wenberg B . MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008; 11: 5078\u20135085.","journal-title":"Blood"},{"key":"BFleu201267_CR2","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1182\/blood-2007-06-097253","volume":"111","author":"JW Tyner","year":"2008","unstructured":"Tyner JW, Walters DK, Willis SG, Luttropp M, Oost J, Loraux M et al. RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood 2008; 111: 2238\u20132245.","journal-title":"Blood"},{"key":"BFleu201267_CR3","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1182\/blood-2007-07-101394","volume":"111","author":"MM Loriaux","year":"2008","unstructured":"Loriaux MM, Levine RL, Tyner JW, Fr\u00f6hling S, Scholl C, Stoffregen EP et al. High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia. Blood 2008; 111: 4788\u20134796.","journal-title":"Blood"},{"key":"BFleu201267_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/1078-0432.CCR-06-2147","volume":"13","author":"HM Kantarjian","year":"2007","unstructured":"Kantarjian HM, Giles F, Quint\u00e1s-Cardama AQ, Cortes J . Important therapeutic targets in chronic myelogenous leukemia. Clin Cancer Res 2007; 13: 1089\u20131097.","journal-title":"Clin Cancer Res"},{"key":"BFleu201267_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","volume":"100","author":"DG Gilliland","year":"2002","unstructured":"Gilliland DG, Griffin JD . The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532\u20131542.","journal-title":"Blood"},{"key":"BFleu201267_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/sj.leu.2401130","volume":"12","author":"H Kiyoi","year":"1998","unstructured":"Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H et al. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 1998; 12: 1333\u20131337.","journal-title":"Leukemia"},{"key":"BFleu201267_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1532\/IJH97.05066","volume":"82","author":"H Kiyoi","year":"2005","unstructured":"Kiyoi H, Yanada M, Ozekia K . Clinical significance of FLT3 in leukemia. Int J Hematol 2005; 82: 85\u201392.","journal-title":"Int J Hematol"},{"key":"BFleu201267_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/sj.leu.2404246","volume":"20","author":"J Cloos","year":"2006","unstructured":"Cloos J, Goemans BF, Hess CJ, Oostveen JW, Waisfisz Q, Corthals S et al. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia 2006; 20: 1217\u20131220.","journal-title":"Leukemia"},{"key":"BFleu201267_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa074306","volume":"358","author":"RF Schlenk","year":"2008","unstructured":"Schlenk RF, Dohner K, Krauter J, Fr\u00f6hling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909\u20131918.","journal-title":"N Engl J Med"},{"key":"BFleu201267_CR10","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1182\/blood-2006-04-015743","volume":"108","author":"M Levis","year":"2006","unstructured":"Levis M, Brown P, Smith BD, Stine A, Pham R, Stone R et al. Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors. Blood 2006; 108: 3477\u20133483.","journal-title":"Blood"},{"key":"BFleu201267_CR11","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1182\/blood-2006-04-015487","volume":"108","author":"S Knapper","year":"2006","unstructured":"Knapper S, Mills KI, Gilkes AF, Austin SJ, Walsh V, Burnett AK . The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases. Blood 2006; 108: 3494\u20133503.","journal-title":"Blood"},{"key":"BFleu201267_CR12","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1182\/blood-2009-05-222034","volume":"114","author":"PP Zarrinkar","year":"2009","unstructured":"Zarrinkar PP, Gunawardane RN, Cramer MD, Gardner MF, Brigham D, Belli B et al. AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood 2009; 114: 2984\u20132992.","journal-title":"Blood"},{"key":"BFleu201267_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/leu.2008.19","volume":"22","author":"A Renneville","year":"2008","unstructured":"Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, Fenaux P et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia 2008; 22: 915\u2013931.","journal-title":"Leukemia"},{"key":"BFleu201267_CR14","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1182\/blood-2007-07-100362","volume":"111","author":"S Boehrer","year":"2008","unstructured":"Boehrer S, Ad\u00e8s L, Braun T, Galluzzi L, Grosjean J, Fabre C et al. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood 2008; 111: 2170\u20132180.","journal-title":"Blood"},{"key":"BFleu201267_CR15","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1182\/blood-2005-02-0488","volume":"106","author":"K Stegmaier","year":"2005","unstructured":"Stegmaier K, Corsello SM, Ross KN, Wong JS, DeAngelo DJ, Golub TR . Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood 2005; 106: 2841\u20132848.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:10:28Z","timestamp":1648739428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,9]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFleu201267"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.67","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,9]]},"assertion":[{"value":"9 March 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}